Separate vials are better for staggered titration (start retatrutide alone first, then add cagrilintide at Week 9) and for users who have GI sensitivity
Daily dose: 1,165mcg (1.165mg) total blend This breaks down to approximately: 850mcg GHK-Cu 165mcg TB-500 165mcg BPC-157 Administration: Once daily, subcutaneous injection Cycle length: 4 weeks initial assessment Schedule: Daily injection at a consistent time, preferably morning At this dose level, you're working with approximately half the standard protocol
Alvarez XA 1 , Laredo M, Corzo D, Fernndez-Novoa L, Mouzo R, Perea JE, Daniele D, Cacabelos R
Related Articles Like what you read
Typically, excess vitamin B12 exits the body through urine and does not pose serious toxicity concerns
When patients want to remove SKs without using Eskata, we typically recommend wither CO2 laser, TCA cross with curettage, or a Q-Switched laser